Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
52,468,722
-
Share change
-
+11,866,415
-
Total reported value
-
$245,057,464
-
Put/Call ratio
-
85%
-
Price per share
-
$4.67
-
Number of holders
-
81
-
Value change
-
+$62,459,641
-
Number of buys
-
52
-
Number of sells
-
18
Institutional Holders of CTI BIOPHARMA CORP - COM (CTIC) as of Q1 2022
As of 31 Mar 2022,
CTI BIOPHARMA CORP - COM (CTIC) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,468,722 shares.
The largest 10 holders included
BVF INC/IL, Lion Point Capital, LP, Stonepine Capital Management, LLC, Bleichroeder LP, VANGUARD GROUP INC, SILVERARC CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, Sofinnova Investments, Inc., TWO SIGMA INVESTMENTS, LP, and BlackRock Inc..
This page lists
81
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.